(47) research results showed that the serum concentration of CXCL9 in oral squamous cell carcinoma (OSCC) patients can be used as a diagnostic indicator to predict tumor progression and overall survival. This evidence concerns the gene CXCL9 and oral cavity squamous cell carcinoma.